IbsC is a small toxin protein in Escherichia coli, whose expression is repressed by a cis-acting small noncoding RNA, SibC (renamed from RygC or QUAD1c).
1,2 Overexpression of IbsC or the absence of SibC transcription induces the expression of both psp operon (pspABCDE) and pspG gene encoding phage shock proteins, 1 whose expression were known to be induced by multiple environment stresses or agents such as filamentous phage infection, osmotic shock, continued incubation in stationary phase, heat shock, and ethanol treatment. 4, 5 Although exogenous overexpression of IbsC leads to cell death, physiological roles of IbsC remain unknown especially because the strain without ibsC gene in the chromosome shows no growth defects.
1 Considering that only Psp proteins are induced by expression of IbsC, not by other similar small toxin proteins such as LdrD, ShoB, and TisB, 1 the role of IbsC might specifically be related to phage shock proteins.
The psp operon is transcribed from pspA promoter by RNA polymerase holoenzyme containing the alternative stress-responsive sigma factor 54 (σ 54 ). 5 Transcription from pspA promoter requires PspF as an activator protein that binds to the upstream region of the core promoter elements.
6,7
Furthermore, PspA inhibits the σ 54 -dependent pspA transcription by interacting with PspF and exerting its negative effects on transcription activation by PspF. 8 Since the IbsC expression causes the induction of pspA transcription, it is attempting to see how the signal of IbsC gets transduced into the transcription activation. The mechanism involved in linking IbsC to pspA transcription is essential for understanding not only the physiological functions of IbsC, but also the regulation mechanism of transcription from σ 54 -dependent promoters in response to environmental stresses. To understand the molecular mechanism of the pspA induction by IbsC, it is necessary to know which factors are involved in the activation of pspA transcription under conditions of IbsC expression. Although an in vitro transcription system for pspA promoter analysis was previously set up, 8 it is difficult to identify in vitro transcripts because their transcription termination sites are unclear. To overcome the drawback of the previous in vitro transcription system, in this study, we constructed plasmid pPR56 containing a transcription fusion of pspA promoter and rnpB terminator by replacing the rnpB promoter-containing DNA fragment of pLMd23-wt with the pspA promoter-containing fragment.
9,10 The pspA promoter-containing fragment spanning from −320 through +56 of pspA, which also includes two UAS sequences (UAS I and UAS II) as PspF-binding sites and the IHF binding site, 6 was subcloned into the BamHI/ EcoRI linearlized pLMd23-wt not having the rnpB promotercontaining DNA fragment, to generate the fusion plasmid pPR56 (Fig. 1) . The rnpB terminator region in the fusion construct contained the rnpB sequence from +331 to +1286, which includes the three rnpB terminators T1, T2, and T3 leading to transcription termination at +413, +526, and +638, respectively. Therefore, this pPR56 construct was designed to generate pspA-rnpB fusion transcripts of 146 nt terminating at T1 (pspAT1), 259 nt at T2 (pspAT2), and 371 nt at T3 (pspAT3) if transcription starts at the transcription initiation site of pspA. Using supercoiled plasmid pPR56 DNA as a template, in vitro transcription was carried out by adding Eσ 54 and PspF. The pspAT1 transcript of 145 nt was produced as a major band although minor pspAT2 and pspAT3 products were also observed (Fig. 2) . The increased abundance of three transcripts was observed with the incremental amount of PspF protein, while RNA I 11 of 108 nt (a transcript transcribed from its own σ 70 specific promoter of the plasmid DNA) was not produced. In contrast, the same transcription reaction performed with Eσ 70 did not produce the pspAT transcripts. Instead, this reaction generated RNA I. All our data confirmed that the pspA transcripts were produced from the σ 54 -specific pspA promoter of pPR56. To Figure 1 . Schematic representation of pPR56 transcription fusion. The pspA promoter region (−320 to +56) was fused to the rnpB terminator region (+331 to +1286). Three transcripts are possible from this construct by transcription termination at +413 (T1), +526 (T2), and +638 (T3): pspAT1 of 145 nt, pspAT2 of 258 nt, and pspAT3 of 371 nt. The arrow indicates the transcription start site of pspA (+1). PpspA, pspA promoter; I and II, UAS I and II as PspF binding sites; IHF, IHF binding site; E, the 7-bp EcoRI linker as the fusion site. Notes search factors involved in the pspA induction by IbsC, in vitro transcriptional analysis with extracts from cells grown under the IbsC expression condition is necessary. Therefore, we prepared an S150 fraction from E. coli lysates as an in vivo-mimic transcription machinery for the pspA induction by IbsC. When σ 54 and PspF were added into the S150 fraction, pspAT transcripts were produced and their production was increased with the increasing amount of PspF, suggesting that the S150 fraction can be used as an in vivo mimicry for analysis of pspA induction by IbsC.
In conclusion, our results show that the pRS56 fusion was appropriately constructed for efficient analysis of in vitro transcription from the σ 54 -specific pspA promoter. The in vitro transcription system including the utilization of S100 we set up in this study can be used to analyze factors involved in transcription induction of pspA by IbsC.
Experimental Section
Construction of a Template DNA for Analysis of Transcription from pspA Promoter. A fusion plasmid containing both pspA promoter-and rnpB terminator-regions was constructed from plasmid pLMd23-wt, which was a derivative of pGEM3 (Promega) carrying the rnpB transcription unit. 10 The BamHI-EcoRI fragment of pLMd23-wt was replaced with a pspA promoter-containing DNA fragment. The promoter-containing DNA fragment was obtained by PCR with a primer pair of BHIpspA-320 (5'-CGC GGA TCC GCA GTT AAG GGA AAT AAA CG-3') and ERIpspAre+56 (5'-CCG GAA TTC AGAA AAA ATA CCC ATA ATG TTG-3'). The PCR products were then digested with BamHI and EcoRI, and cloned into the BamHI-EcoRI site of pLMd23-wt to generate the fusion plasmid pPR56, carrying the promoter regions from −320 to +56 of pspA. For the plasmid construction and propagation, E. coli JM109 was used as the bacterial host strain. In vitro Transcription by E.coli Polymerase. Plasmid pPR56 DNA was used as a template for in vitro transcription. In vitro transcription reaction was carried out basically as described previously, 2 with minor modification. Proteins σ 54 and PspF were purified using the corresponding clones from the ASKA library, 13 as previously described. 2 Eσ 54 was prepared either by combining the core enzyme and σ 54 in a ratio of 1:4 or by supplementing σ 54 to S150 fraction (containing RNA polymerase core). For preparing the S150 fraction, S30 fraction from E. coli strain MG1655 prepared as described previously 14 and the S30 fraction was further subjected to ultracentrifugation for 2 h at 4°C at 150,000 × g. The S150 fraction was used as a crude RNA polymerase. Briefly, Eσ 54 (the core enzyme of 90 nM) or S150 fraction (about 0.3 μg/μL protein) supplemented with σ 54 of 360 nM was incubated at 37°C for 5 min in the reaction buffer (40 mM Tris-HCl, pH 8.0, 10 mM MgCl 2 , 10 mM DTT, 150 mM KCl, 0.05% Triton X-100) with 6 nM of template DNA and 40 mM rATP. The reaction was started by adding rNTP mixtures (500 µM of GTP, UTP, and 25 µM of CTP including 10 µCi of [α-32 P]CTP) in the presence of varying amounts of PspF protein (0 to 400 nM). After 25 min, the reaction was terminated by the addition of the same volume of phenol:chloroform (5:1) mixture and the products were ethanol-precipitated. In vitro transcription reaction with Eσ 70 (Epicentre) was also conducted as described above except for using 1 unit of Eσ
70
. The products were analyzed on a 5% polyacrylamide sequencing gel containing 7 M urea and quantitated by BAS1500 (Fuji). 
